116 related articles for article (PubMed ID: 3818496)
1. Pharmacokinetics of mezlocillin in patients with hepatobiliary dysfunction.
Meyers BR; Srulevitch ES; Sacks HS; Hirschman SZ; Worner TM; Wormser GP; Jacobson J
J Antimicrob Chemother; 1986 Dec; 18(6):709-13. PubMed ID: 3818496
[TBL] [Abstract][Full Text] [Related]
2. [Clinical studies on the biliary excretion of mezlocillin, especially in cases with liver dysfunction].
Maeba T; Hashimoto T; Takeda T; Shiraishi Y; Oike H; Wakabayashi H; Omori G; Indo S; Kunikata E; Hayashi M
Jpn J Antibiot; 1986 Jan; 39(1):116-20. PubMed ID: 3702053
[TBL] [Abstract][Full Text] [Related]
3. Biliary excretion of mezlocillin in patients with hepatic disease.
Hildebrandt R; Gundert-Remy U; Raedsch R; Sieg A; Stiehl A
Int J Clin Pharmacol Ther; 1995 Jul; 33(7):384-7. PubMed ID: 7582392
[TBL] [Abstract][Full Text] [Related]
4. [The effect of infusion rate on pharmacokinetic parameters of azlocillin and mezlocillin].
Haen E; Remien J; Richter E; Frank U; Adam D
Arzneimittelforschung; 1985; 35(5):864-8. PubMed ID: 4026911
[TBL] [Abstract][Full Text] [Related]
5. [HPLC study of the pharmacokinetics of mezlocillin administered by 30-minute infusion and comparison with the direct intravenous route].
Jehl F; Peter JD; Monteil H; Dupeyron JP; Minck R
Pathol Biol (Paris); 1984 May; 32(5):312-7. PubMed ID: 6739140
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of mezlocillin and sulbactam under continuous veno-venous hemodialysis (CVVHD) in intensive care patients with acute renal failure.
Rohde B; Werner U; Hickstein H; Ehmcke H; Drewelow B
Eur J Clin Pharmacol; 1997; 53(2):111-5. PubMed ID: 9403281
[TBL] [Abstract][Full Text] [Related]
7. [Chemotherapy of biliary tract infections (XXIV). Biliary excretion and gallbladder tissue levels of mezlocillin].
Kobayashi N; Tanimura H; Huang WF; Sekiya T; Takahashi H; Sato T; Yoshida K; Hikasa Y
Jpn J Antibiot; 1984 Apr; 37(4):597-604. PubMed ID: 6471380
[TBL] [Abstract][Full Text] [Related]
8. The biliary excretion and pharmacokinetics of mezlocillin in jaundiced patients with external bile drainage.
Dooley JS; Gooding A; Hamilton-Miller JM; Brumfitt W; Sherlock S
Liver; 1983 Aug; 3(4):201-6. PubMed ID: 6672502
[TBL] [Abstract][Full Text] [Related]
9. [Pharmacokinetics and dosage of mezlocillin administered by intravenous infusion].
Modr Z; Dvorácek K; Janků I; Krebs V
Infection; 1982; 10 Suppl 3():S191-5. PubMed ID: 6218111
[TBL] [Abstract][Full Text] [Related]
10. Tissue concentrations of mezlocillin in benign hypertrophy of the prostate following intravenous bolus injection versus infusion.
Naber KG; Adam D
J Antimicrob Chemother; 1983 May; 11 Suppl C():17-23. PubMed ID: 6194144
[TBL] [Abstract][Full Text] [Related]
11. Effect of dose on pharmacokinetics and serum bactericidal activity of mezlocillin.
Flaherty JF; Barriere SL; Mordenti J; Gambertoglio JG
Antimicrob Agents Chemother; 1987 Jun; 31(6):895-8. PubMed ID: 3619421
[TBL] [Abstract][Full Text] [Related]
12. Mezlocillin pharmacokinetics in pediatric oncology patients.
Kramer WG; Pickering LK; Culbert S; Frankel LS
Antimicrob Agents Chemother; 1984 Jan; 25(1):62-4. PubMed ID: 6703685
[TBL] [Abstract][Full Text] [Related]
13. Investigation of mezlocillin disposition with a porcine model.
DiPiro JT; Davis JB; Boudinot FD; Cheung RP; Sisley JF
Biopharm Drug Dispos; 1989; 10(6):563-72. PubMed ID: 2611357
[TBL] [Abstract][Full Text] [Related]
14. Antibiotic therapy in biliary tract infections: clinical experiences with mezlocillin.
Cristiano P; Iovene MR; Cioffi R; Salerno RA; Sicolo A; Cristinzio G; Paradisi F
Chemioterapia; 1984 Jun; 3(3):178-82. PubMed ID: 6529774
[TBL] [Abstract][Full Text] [Related]
15. Dose-dependent pharmacokinetics of azlocillin compared to mezlocillin.
Bergan T; Thorsteinsson SB; Steingrimsson O
Chemotherapy; 1982; 28(3):160-70. PubMed ID: 6212204
[TBL] [Abstract][Full Text] [Related]
16. Kinetics of penetration and clearance of mezlocillin in the bronchopulmonary tract.
Braga PC; Marchi E; Scaglione F; Scarpazza G; Faravelli M; Fraschini F
Int J Clin Pharmacol Res; 1984; 4(5):361-5. PubMed ID: 6519850
[TBL] [Abstract][Full Text] [Related]
17. Mezlocillin kinetics in hepatic insufficiency.
Bunke CM; Aronoff GR; Brier ME; Sloan RS; Luft FC
Clin Pharmacol Ther; 1983 Jan; 33(1):73-6. PubMed ID: 6217018
[TBL] [Abstract][Full Text] [Related]
18. High serum concentrations of mezlocillin in a critically ill patient with renal and hepatic dysfunction.
Cooper BE; Nester TJ; Armstrong DK; Dasta JF
Clin Pharm; 1986 Sep; 5(9):764-6. PubMed ID: 3757449
[No Abstract] [Full Text] [Related]
19. Developmental pharmacokinetics of mezlocillin in newborn infants.
Janicke DM; Rubio TT; Wirth FH; Karotkin EH; Jusko WJ
J Pediatr; 1984 May; 104(5):773-81. PubMed ID: 6716226
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic properties of mezlocillin in ambulatory elderly subjects.
Meyers BR; Mendelson MH; Srulevitch-Chin E; Bradbury K; McMurdo L; Hirschman SZ
J Clin Pharmacol; 1987 Sep; 27(9):678-81. PubMed ID: 3680597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
